The invention relates to methods of treating a disease or condition, wherein expression or activity of soluble CLCA1 is up-regulated, by administering inhibitors of soluble CLCA1. The invention also relates to methods of isolating soluble CLCA1 from a bodily fluid.
申请公布号
WO2004105793(A3)
申请公布日期
2005.03.03
申请号
WO2004US16742
申请日期
2004.05.27
申请人
WYETH;LONG, ANDREW, J.;WOOD, CLIVE, R.;BOWMAN, MICHAEL;GOLDMAN, SAMUEL, J.;SYPEK, JOSEPH, P.
发明人
LONG, ANDREW, J.;WOOD, CLIVE, R.;BOWMAN, MICHAEL;GOLDMAN, SAMUEL, J.;SYPEK, JOSEPH, P.